EFFICACY OF GUSELKUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE NOT IN CLINICAL RESPONSE AT WEEK 12: RESULTS FROM THE GALAXI 1 STUDY

Remo Panaccione  ¹     Anita Afzali  ²     Geert R. D'Haens  ³     Leonardo Salese  ⁴     Natalie Terry  ⁴     Aparna Sahoo  ⁴     Mary Ellen Frustaci  ⁴     Zijiang Yang  ⁴     Eran Zittan  ^{5, 6}     Silvio Danese  ⁷     Tadakazu Hisamatsu  ^8    
1 University of Calgary, Calgary, Canada
² University of Cincinnati, Cincinnati, United States
³ Amsterdam University Medical Centre, Amsterdam, Netherlands
⁴ Janssen Research & Development, LLC, Spring House, United States
⁵ Emek Medical Center, Afula, Israel
⁶ The Rappaport Faculty of Medicine Technion-Israel Institute of Technology, Haifa, Israel
⁷ IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milano, Italy
⁸ Kyorin University, Tokyo, Japan

Topic
Endoscopy, Histopathology, IBD

Session
The new kids on the block for IBD: Part 1

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)